#1484 Systematic Review and Meta-analysis of the Association Between CONUT Score and High-Grade Postoperative Complications in Bladder Cancer Patients Undergoing Radical Cystectomy
#0041
Big Database: Multicenter prospective study of histoscan-guided prostate biopsy in the early detection of prostate cancer
Y. Aleksandrovich1, A. Vasilyev2, P. Arutyunyan2, A. Govorov2, C. Yang3, D. Pushkar2
1Botkin
Hospital, Department of Urology, Moscow, Russia
2A.I. Evdokimov Moscow State University of Medicine and Dentistry,
Department of Urology, Moscow, Russia
3Changbin Show Chwan Memorial Hospital, Department of Urology,
Changhua County, Taiwan
Introduction:
The effectiveness of a standard 12-core prostate biopsy largely depends on the experience of the doctor. The most promising, non - invasive methods of additional imaging in prostate biopsy is histoscan. Using the latest software "True Targeting" allows you to perform a targeted biopsy in real time. This study is to evaluate the effectiveness of performing prostate biopsy under the control of histoscan in the one-day stay unit.
Material and methods:
From May 2021 to December 2024. In the one-day stay unit on the basis of 10 multidisciplinary clinics 3650 patients with suspected prostate cancer underwent transrectal histoscan-guided prostate biopsy with "True Targeting" software.
Results:
The average prostate-specific antigen value was 13.23 ng/ml (range: 0.5 to 1900 ng/ml). The average age of the patients was 66 years old, and the average prostate volume was 54.89 cm3. There were 2997 patients (82%) having his first biopsy, and the other 658 patients (18%) having previous negative biopsy with non histoscan-guided biopsy. The presence of prostate cancer in close relatives was noted in 146 patients (4%). Among them, prostate cancer was detected in 126 patients, which is 86%. Suspicious sites were mainly located in the anterior sections of the prostate, which are usually missed when performing a standard transrectal biopsy. The overall incidence of prostate cancer was 64%, and with a standard biopsy this figure was 19%, while with a histoscan-targeted biopsy prostate cancer was diagnosed in 8% of cases. The average time of a transrectal histoscan-guided prostate biopsy is 16 minutes.